Chicago, Illinois, United States RMB Funds is the famous VC, which was founded in 2005. The main office of represented VC is situated in the Chicago. The venture was found in North America in United States.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular fund investment industries, there are Medical, Pharmaceutical. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight FineEx.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the RMB Funds, startups are often financed by YuanMing Capital, Oriza Seed Capital (Oriza Yuandian), Grains Valley Venture Capital. The meaningful sponsors for the fund in investment in the same round are YuanMing Capital, State Development & Investment Corporation (SDIC), Oriza Holdings. In the next rounds fund is usually obtained by YuanMing Capital, Sino-Ocean Capital, Qianbao.com.
The important activity for fund was in 2016. Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
| Fund Name | Location |
| Allegheny Financial Group | Pennsylvania, Pittsburgh, United States |
| Armada Capital | Distrito Federal, Mexico, Mexico City |
| Axilium Holding | - |
| CAC | California, San Diego, United States |
| Emerson Ventures | Canada, Ontario, Toronto |
| Essential Pharma | Japan, Tokyo |
| Fishman Group | Michigan, Southfield, United States |
| Handok | - |
| ITAI GmbH | - |
| Jilin University Alumni Fund | - |
| Kingdom Capital | China, Fujian, Xiamen |
| Nuwa Capital | Dubai, United Arab Emirates |
| Start Smart Labs | California, Palo Alto, United States |
| Sugar Capital | California, San Francisco, United States |
| The Bosch D.N.A accelerator | Bangalore, India, Karnataka |
| Weizhong Xiang Jijin | China, Jiangsu, Nanjing |
| Xingyuan Capital | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ascentage Pharma | $77M | 26 Dec 2016 | China, Gusu District | ||
FineEx | 20 Dec 2016 | Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ascentage Pharma | $77M | 26 Dec 2016 | China, Gusu District | ||
FineEx | 20 Dec 2016 | Shanghai |
